Recently, a novel tumor microenvironment ROS/GSH dual-responsive nanoplatform consisting of chemophotodynamic therapy and synergistical control-release PTX has been designed to induce the release of DAMPs after tumor cell pyroptosis, boosting the curative effect of anti-PD-1 treatment in a CT26 tumor model (177). Here, PDCD1 is linked to neoplasm.